PMID- 37359409 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230701 IS - 2398-8835 (Electronic) IS - 2398-8835 (Linking) VI - 6 IP - 6 DP - 2023 Jun TI - Better understanding extrapulmonary tuberculosis: A scoping review of public health impact in Pakistan, Afghanistan, India, and Bangladesh. PG - e1357 LID - 10.1002/hsr2.1357 [doi] LID - e1357 AB - BACKGROUND AND AIMS: South Asian countries, including Pakistan, Afghanistan, India, and Bangladesh, have a high prevalence of pulmonary and extra-pulmonary tuberculosis (EPTB). This prevalence is influenced by various risk factors such as ethnicity, nutrition, socioeconomic disparities, high out-of-pocket healthcare expenses, and specific Mycobacterium Tuberculosis (TB) lineages. The COVID-19 pandemic has likely hindered access to healthcare and led to under-reporting of EPTB cases nationally and internationally. This rapid review aimed to summarize the literature on the prevalence and disease outcomes of EPTB in the mentioned countries, compare the situations across countries, and provide recommendations for future action. METHODS: The review utilized PubMed and Google Scholar databases to search for literature on EPTB in South Asian countries. The search string included keywords related to different forms of EPTB and the countries of interest while excluding pulmonary tuberculosis. RESULTS: The results showed that both TB, including drug-resistant TB, and EPTB are prevalent and burdensome in South Asia. In Pakistan, pleural TB was the most commonly reported form of EPTB, followed by lymph node TB, abdominal TB, osteoarticular TB, Central Nervous System TB, and miliary TB. In India, lymph node TB(LNTB) was more common among EPTB cases. Bangladesh reported a high prevalence of EPTB involving lymph node, pleura, and abdomen, while Afghanistan had a higher prevalence of forms such as LNTB and tuberculous meningitis. CONCLUSION: In conclusion, the prevalence of EPTB in Pakistan, Afghanistan, India, and Bangladesh is alarmingly high and negatively impacts population health. Effective measures are needed for treatment and management of this condition, along with addressing current and future challenges. Strengthening the evidence base through surveillance and research is crucial to understand the patterns and significant factors related to EPTB, requiring investment in these areas. CI - (c) 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC. FAU - Jawed, Areesha AU - Jawed A AD - Department of Medicine Dow Medical College Karachi Pakistan. FAU - Tharwani, Zoaib Habib AU - Tharwani ZH AD - Department of Medicine Dow Medical College Karachi Pakistan. FAU - Siddiqui, Amna AU - Siddiqui A AUID- ORCID: 0000-0001-9372-0362 AD - Karachi Medical and Dental College Karachi Pakistan. FAU - Masood, Waniyah AU - Masood W AD - Department of Medicine Dow Medical College Karachi Pakistan. FAU - Qamar, Khulud AU - Qamar K AD - Department of Medicine Dow Medical College Karachi Pakistan. FAU - Islam, Zarmina AU - Islam Z AUID- ORCID: 0000-0002-0485-0032 AD - Department of Medicine Dow Medical College Karachi Pakistan. FAU - Jawed, Aleeza AU - Jawed A AD - The Ziauddin Medical University Karachi Sindh Pakistan. FAU - Shah, Muzhgan AU - Shah M AD - Bolan University of Medical and Health Sciences Quetta Pakistan. FAU - Adnan, Alishba AU - Adnan A AD - Karachi Medical and Dental College Karachi Pakistan. FAU - Essar, Mohammad Yasir AU - Essar MY AUID- ORCID: 0000-0002-6554-7619 AD - Kabul University of Medical Sciences Kabul Afghanistan. FAU - Rackimuthu, Sudhan AU - Rackimuthu S AD - Father Muller Medical College Mangalore Karnataka India. FAU - Head, Michael G AU - Head MG AD - Clinical Informatics Research Unit, Faculty of Medicine University of Southampton Southampton UK. LA - eng PT - Journal Article DEP - 20230622 PL - United States TA - Health Sci Rep JT - Health science reports JID - 101728855 PMC - PMC10287908 OTO - NOTNLM OT - LNTB OT - Mycobacterium tuberculosis OT - SARS-COV-2 OT - South Asia OT - TBM OT - extrapulmonary tuberculosis COIS- The authors declare no conflict of interest. EDAT- 2023/06/26 19:07 MHDA- 2023/06/26 19:08 PMCR- 2023/06/22 CRDT- 2023/06/26 12:23 PHST- 2023/04/04 00:00 [received] PHST- 2023/06/08 00:00 [accepted] PHST- 2023/06/26 19:08 [medline] PHST- 2023/06/26 19:07 [pubmed] PHST- 2023/06/26 12:23 [entrez] PHST- 2023/06/22 00:00 [pmc-release] AID - HSR21357 [pii] AID - 10.1002/hsr2.1357 [doi] PST - epublish SO - Health Sci Rep. 2023 Jun 22;6(6):e1357. doi: 10.1002/hsr2.1357. eCollection 2023 Jun.